Genocea Biosciences

+$0.02 (+1.15%) Today
-$0.03 (-1.70%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GNCA and other ETFs, options, and stocks.

About GNCA

Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. The firm uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses.

CEO
William D. Clark
Employees
72
Headquarters
Cambridge, Massachusetts
Founded
2006

GNCA Key Statistics

Market Cap
100.35M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
158.83K
High Today
$1.81
Low Today
$1.69
Open Price
$1.73
Volume
133.97K
52 Week High
$4.05
52 Week Low
$1.65

GNCA Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure